Annual Non Current Assets
$77.91 M
+$2.95 M+3.93%
December 31, 2023
Summary
- As of February 7, 2025, TCRX annual long term assets is $77.91 million, with the most recent change of +$2.95 million (+3.93%) on December 31, 2023.
- During the last 3 years, TCRX annual non current assets has risen by +$64.62 million (+486.11%).
- TCRX annual non current assets is now at all-time high.
Performance
TCRX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$73.94 M
-$1.40 M-1.86%
September 30, 2024
Summary
- As of February 7, 2025, TCRX quarterly long term assets is $73.94 million, with the most recent change of -$1.40 million (-1.86%) on September 30, 2024.
- Over the past year, TCRX quarterly non current assets has increased by +$130.00 thousand (+0.18%).
- TCRX quarterly non current assets is now -5.10% below its all-time high of $77.91 million, reached on December 31, 2023.
Performance
TCRX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
TCRX Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +3.9% | +0.2% |
3 y3 years | +486.1% | +0.2% |
5 y5 years | +1012.4% | +0.2% |
TCRX Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +247.0% | -5.1% | +229.3% |
5 y | 5-year | at high | +1012.4% | -5.1% | +456.3% |
alltime | all time | at high | +1012.4% | -5.1% | +456.3% |
TScan Therapeutics Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $73.94 M(-1.9%) |
Jun 2024 | - | $75.34 M(-1.0%) |
Mar 2024 | - | $76.11 M(-2.3%) |
Dec 2023 | $194.24 M(+56.5%) | $77.91 M(+5.6%) |
Sep 2023 | - | $73.81 M(-1.2%) |
Jun 2023 | - | $74.70 M(+2.8%) |
Mar 2023 | - | $72.67 M(-3.1%) |
Dec 2022 | $124.13 M | $74.96 M(+208.8%) |
Sep 2022 | - | $24.28 M(+5.3%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $23.05 M(+2.7%) |
Mar 2022 | - | $22.45 M(+0.0%) |
Dec 2021 | $165.65 M(+354.5%) | $22.45 M(+25.5%) |
Sep 2021 | - | $17.89 M(-10.3%) |
Jun 2021 | - | $19.94 M(+16.8%) |
Mar 2021 | - | $17.07 M(+28.4%) |
Dec 2020 | $36.45 M(-14.0%) | - |
Dec 2020 | - | $13.29 M |
Dec 2019 | $42.38 M | - |
FAQ
- What is TScan Therapeutics annual long term assets?
- What is the all time high annual non current assets for TScan Therapeutics?
- What is TScan Therapeutics annual non current assets year-on-year change?
- What is TScan Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for TScan Therapeutics?
- What is TScan Therapeutics quarterly non current assets year-on-year change?
What is TScan Therapeutics annual long term assets?
The current annual non current assets of TCRX is $77.91 M
What is the all time high annual non current assets for TScan Therapeutics?
TScan Therapeutics all-time high annual long term assets is $77.91 M
What is TScan Therapeutics annual non current assets year-on-year change?
Over the past year, TCRX annual long term assets has changed by +$2.95 M (+3.93%)
What is TScan Therapeutics quarterly long term assets?
The current quarterly non current assets of TCRX is $73.94 M
What is the all time high quarterly non current assets for TScan Therapeutics?
TScan Therapeutics all-time high quarterly long term assets is $77.91 M
What is TScan Therapeutics quarterly non current assets year-on-year change?
Over the past year, TCRX quarterly long term assets has changed by +$130.00 K (+0.18%)